Fierce Biotech1 min read
saveVertex signs $220M deal with Genomics to re-up long-running discovery pact
Vertex Pharmaceuticals has re-upped its ties with sequencing specialist Genomics in a deal worth up to $220 million, signing on for an extra four years on top of the eight the companies have already worked together.
comments(0)
5-min edit window · permanent after that